Overview

A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

Status:
Terminated
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of amifostine (ETHYOL) on decreasing the rate and severity of nerve dysfunction or neuropathy (numbness and tingling in hands and feet) associated with FOLFOX chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborators:
AstraZeneca
MedImmune LLC
Treatments:
Amifostine
Leucovorin
Levoleucovorin
Oxaliplatin